BOT 6.25% 34.0¢ botanix pharmaceuticals ltd

IMO we are at the point where BTX 1503 is effectively at Phase 3...

  1. 2,756 Posts.
    lightbulb Created with Sketch. 588
    IMO we are at the point where BTX 1503 is effectively at Phase 3 and there is a 2/3 chance of advancing to FDA approval.

    ... which would suggest that the company is a tad undervalued.


 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
0.020(6.25%)
Mkt cap ! $615.4M
Open High Low Value Volume
32.0¢ 34.0¢ 32.0¢ $1.776M 5.339M

Buyers (Bids)

No. Vol. Price($)
1 118187 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 698385 8
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.